Clindamycin Mono-Therapy of Hidradenitis Suppurativa Patients: A Single-Center Retrospective Study

BACKGROUND: A rifampicin (RF)-clindamycin (CL) combination therapy is recommended as the first-line treatment for moderate to severe hidradenitis suppurativa (HS). Although the long-term use of RF requires caution due to the possibility of developing resistant bacteria, only a few studies have inves...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Ji Hae, Moon, Su Jin, Shin, Jung U, Kim, Dong Hyun, Yoon, Moon Soo, Lee, Hee Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577909/
https://www.ncbi.nlm.nih.gov/pubmed/34858002
http://dx.doi.org/10.5021/ad.2021.33.6.515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577909/
https://www.ncbi.nlm.nih.gov/pubmed/34858002
http://dx.doi.org/10.5021/ad.2021.33.6.515

Ejemplares similares